Artesia

Apixaban for the Reduction of Thrombo-Embolism in Patients with Device-Detected Sub-Clinical Atrial Fibrillation
Contact phone
517.364.5760
Principal investigator
John Ip, MD, FACC
Trial Category
Heart & Vascular
Trial SubCategory
Atrial Fibrillation
Webform